This page lists the SEC filings reported by Velan Capital Investment Management LP.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-03-28 | Velan Capital Investment Management LP | Outlook Therapeutics, Inc. | 1,250,000 | 5.6% | EDGAR |
| SC 13D/A | 2024-02-09 | Velan Capital Investment Management LP | Jasper Therapeutics, Inc. | 1,188,500 | 7.9% | EDGAR |
| SC 13G/A | 2024-01-29 | Velan Capital Investment Management LP | Edesa Biotech, Inc. | 63,492 | 2.0% | EDGAR |
| SC 13D/A | 2023-08-16 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 9,429,808 | 18.0% | EDGAR |
| SC 13D/A | 2023-08-03 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 9,429,808 | 18.0% | EDGAR |
| SC 13D/A | 2023-06-28 | Velan Capital Investment Management LP | Praxis Precision Medicines, Inc. | 5,185,000 | 4.0% | EDGAR |
| SC 13D/A | 2023-05-19 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 1,659,654 | 18.8% | EDGAR |
| SC 13D | 2023-03-31 | Velan Capital Investment Management LP | ALIMERA SCIENCES INC | 748,838 | 10.0% | EDGAR |
| SC 13D | 2023-03-20 | Velan Capital Investment Management LP | Praxis Precision Medicines, Inc. | 5,185,000 | 9.9% | EDGAR |
| SC 13D | 2023-02-27 | Velan Capital Investment Management LP | Jasper Therapeutics, Inc. | 8,385,000 | 7.7% | EDGAR |
| SC 13G/A | 2023-01-27 | Velan Capital Investment Management LP | Jasper Therapeutics, Inc. | 8,385,000 | 7.7% | EDGAR |
| SC 13G | 2023-01-06 | Velan Capital Investment Management LP | Edesa Biotech, Inc. | 1,777,776 | 8.8% | EDGAR |
| SC 13D/A | 2022-08-26 | Velan Capital Investment Management LP | Radius Health, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2022-07-12 | Velan Capital Investment Management LP | Radius Health, Inc. | 1,821,500 | 3.8% | EDGAR |
| SC 13D/A | 2022-05-25 | Velan Capital Investment Management LP | Radius Health, Inc. | 1,721,500 | 3.6% | EDGAR |
| SC 13D/A | 2022-04-18 | Velan Capital Investment Management LP | Radius Health, Inc. | 1,571,500 | 3.3% | EDGAR |
| SC 13D/A | 2022-03-15 | Velan Capital Investment Management LP | Radius Health, Inc. | 1,371,500 | 2.9% | EDGAR |
| SC 13D | 2022-03-07 | Velan Capital Investment Management LP | Radius Health, Inc. | 1,371,500 | 2.9% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.